IL13 and asthma: However, using a mouse model of IL13-induced mucus hyperplasia and primary cells from asthmatics, inhibiting the heat shock protein 90 (HSP90), upregulated in asthma with geldanamycin, blocked, and even reverted, mucus hyperproduction and goblet cell hyperplasia (Pezzulo et al., 2019).